[
  {
    "reportName": "Condensed Balance Sheet",
    "data": {
      "header": "Condensed Balance Sheet - USD $ in Thousands",
      "period": "Jun. 30, 2024",
      "data": {
        "Restricted cash and restricted cash equivalents": 32135,
        "Investment securities (includes available-for-sale securities of $1,444,223 and $595,187 at fair value with associated amortized cost of $1,443,344 and $596,757, as of June 30, 2024 and December 31, 2023, respectively)": 1566087,
        "Loans held for sale, at fair value": 299186,
        "Loans held for investment, at fair value": 88468,
        "Loans held for investment, at amortized cost (less allowance for credit losses of $51,908 and $54,695, as of June 30, 2024 and December 31, 2023, respectively)": 2172528,
        "Servicing rights": 291329,
        "Property, equipment and software": 246286,
        "Goodwill": 1393505,
        "Intangible assets": 331446,
        "Operating lease right-of-use assets": 83352,
        "Other assets (less allowance for credit losses of $1,509 and $1,837, as of June 30, 2024 and December 31, 2023, respectively)": 737487,
        "Total assets": 419789,
        "Interest-bearing deposits": 22945652,
        "Noninterest-bearing deposits": 51311,
        "Total deposits": 22996963,
        "Accounts payable, accruals and other liabilities": 250,
        "Operating lease liabilities": 100797,
        "Debt": 134021,
        "Residual interests classified as debt": 724,
        "Total liabilities": 26740485,
        "Redeemable preferred stock, $0.00 par value: 100,000,000 and 100,000,000 shares authorized; â€” and 3,234,000 shares outstanding, as of June 30, 2024 and December 31, 2023, respectively": 0,
        "Common stock": 106,
        "Additional paid-in capital": 7601687,
        "Total permanent equity": 5901494,
        "Total liabilities, temporary equity and permanent equity": 32641979
      }
    },
    "periodOfReport": "2024-06-30",
    "dateFiled": "2024-08-06",
    "formType": "10-Q",
    "quarter": "Q2"
  },
  {
    "reportName": "Condensed Statement of Operations and Comprehensive Income",
    "data": {
      "header": "Condensed Statement of Operations and Comprehensive Income - USD $ in Thousands",
      "period": "3 Months Ended",
      "data": {
        "Other": 38637,
        "Total interest income": 674595,
        "Securitizations and warehouses": 17362,
        "Deposits": 231815,
        "Corporate borrowings": 12725,
        "Total interest expense": 262011,
        "Net interest income": 412584,
        "Loan origination, sales, and securitizations": 54872,
        "Servicing": 6659,
        "Technology products and solutions": 85866,
        "Total noninterest income": 186034,
        "Total net revenue": 598618,
        "Technology and product development": 132167,
        "Sales and marketing": 184762,
        "Cost of operations": 109703,
        "General and administrative": 145006,
        "Provision for credit losses": 11640,
        "Total noninterest expense": 583278,
        "Income (loss) before income taxes": 15340,
        "Income tax (expense) benefit": 2064,
        "Net income (loss)": 17404,
        "Unrealized gains on available-for-sale securities, net": 741,
        "Foreign currency translation adjustments, net": 392,
        "Total other comprehensive income (loss)": 605,
        "Weighted average common stock outstanding - basic (in shares)": 1058591943,
        "Weighted average common stock outstanding - diluted (in shares)": 1065171357
      }
    },
    "periodOfReport": "2024-06-30",
    "dateFiled": "2024-08-06",
    "formType": "10-Q",
    "quarter": "Q2"
  },
  {
    "reportName": "Condensed Statement of Cash Flow",
    "data": {
      "header": "Condensed Statement of Cash Flow - USD $ in Thousands",
      "period": "6 Months Ended",
      "data": {
        "Share-based compensation expense": 116139,
        "Depreciation and amortization": 98162,
        "Deferred debt issuance and discount expense": 8207,
        "Gain on extinguishment of convertible debt": 0,
        "Provision for credit losses": 18822,
        "Fair value changes in loans held for investment": 0,
        "Fair value changes in securitization investments": 1537,
        "Changes in loans previously classified as held for sale, net": 787345,
        "Servicing assets": 3201,
        "Other assets": 40974,
        "Accounts payable, accruals and other liabilities": 21013,
        "Net cash provided by (used in) operating activities": 253877,
        "Proceeds from sales of available-for-sale investments": 0,
        "Proceeds from maturities and paydowns of available-for-sale investments": 471007,
        "Proceeds from securitization investments": 22693,
        "Proceeds from non-securitization investments": 2515,
        "Acquisition of businesses, net of cash acquired": 0,
        "Net change in deposits": 4297336,
        "Net change in debt facilities": 964898,
        "Proceeds from other debt issuances": 845250,
        "Purchase of capped calls": 0,
        "Unwind of capped calls": 10180,
        "Proceeds from stock option exercises": 632,
        "Redemption of Series 1 preferred stock": 0,
        "Net cash provided by financing activities": 2318593,
        "Effect of exchange rates on cash and cash equivalents": 99,
        "Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents": 1654826,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period": 3615578,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period": 2731632,
        "Cash and cash equivalents": 2334589,
        "Restricted cash and restricted cash equivalents": 397043,
        "Total cash, cash equivalents, restricted cash and restricted cash equivalents": 2731632,
        "Extinguishment of convertible notes by issuance of common stock": 593910,
        "Deposits credited but not yet received in cash": 78964,
        "Available-for-sale securities purchased but unpaid": 0,
        "Deconsolidation of securitization and residual debt": 0
      }
    },
    "periodOfReport": "2024-06-30",
    "dateFiled": "2024-08-06",
    "formType": "10-Q",
    "quarter": "Q2"
  }
]